Technology | Ultrasound Imaging | July 03, 2018

Neural Analytics Inc. Receives CE Mark for Robotic Ultrasound System

Technology enables clinicians to non-invasively evaluate brain blood flow characteristics for management of patients with neurological disease

Neural Analytics Inc. Receives CE Mark for Robotic Ultrasound System

July 3, 2018 — Medical robotics company Neural Analytics Inc. announced that it received CE Mark for its NeuralBot System, a robotic assistance technology which automatically adjusts orientation and position of its ultrasound products under the guidance of a healthcare professional. The system has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA). When used with its previously cleared Lucid M1 Transcranial Doppler Ultrasound System, it can assist clinicians to non-invasively monitor a patient’s brain blood flow characteristics and can provide information to diagnose a variety of neurological disorders.

“This technology allows us to look inside the brain, evaluate blood flow characteristics and track emboli in patients. It provides us with critical information on brain health in real-time to help us diagnose neurological disorders, prior to the need for additional, more invasive testing,” said Prof. Claudio Baracchini, M.D., FESO, director of the Stroke Unit and Neurosonology Lab at the University of Padua (Italy) and president of the European Society of Neurosonology and Cerebral Hemodynamics (ESNCH).

In April, at the 23rd ESNCH Meeting in Prague, Neural Analytics presented research data that demonstrated there was no statistical difference between ultrasound blood flow data collected with its NeuralBot System or data collected manually by an expert technician with its traditional ultrasound platform.(5)

The worldwide prevalence of stroke in 2010 was 33 million cases, with 16.9 million people having their first stroke.(1) Stroke claims a life every five seconds and is the second most common cause of death accounting for over 11.9 percent total deaths worldwide.(2) The burden of disease caused by stroke is set to double worldwide by 2030.(3) The number of stroke events in Europe is projected to rise from 1.1 million to 1.5 million per year by 2025.(4) Stroke is a time sensitive disease and requires intervention within 24 hours of onset of symptoms. Incorrect assessment of large vessel stroke leads to misdiagnosis and treatment delays, resulting in death or disability for stroke patients. Despite recent advances in life-saving treatments for acute ischemic stroke, less than 5 percent of stroke patients qualify for intervention because they do not present early enough.(6)

Neural Analytics will immediately commercialize the NeuralBot System with its currently available Lucid M1 TCD System in Europe as the ‘Lucid Robotic System’.

For more information: www.neuralanalytics.com

References

(1) Lozano R, Naghavi M, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2095–2128.
(2) World Health Organisation. (2014). The top 10 causes of death. Available: http://www.who. int/mediacentre/factsheets/fs310/en/ int/mediacentre/factsheets/fs310/en/.
(3) Feigin VL, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet, Early Online Publication, 24 October 2013
(4) T. Truelsena, et al. Stroke incidence and prevalence in Europe: a review of available data. European Journal of Neurology. 2006,13: 581–598
(5) Fully Automated Transcranial Doppler Ultrasound Insonation of the MCA using 5 Degree of Freedom Robotically Actuated Probe System
(6) Christopher R. Bernheisel, MD, Jeffrey D. Schlaudecker, MD, Katelyn Leopold, MD. Subacute Management of Ischemic Stroke. American Family Physician, 2011 Dec 15;84(12):1383-1388

Related Content

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions
News | Breast Imaging | December 17, 2020
December 17, 2020 — Hologic, Inc.
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.

Using 14 points in the lungs, researchers looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, they found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Image courtesy of Umberto Sabatini

News | Coronavirus (COVID-19) | December 11, 2020
December 11, 2020 — For some, COVID-19 can resul
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020

Medical imaging artificial intelligence (AI) vendor Avicenna.AI announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.
 

News | Stroke | December 01, 2020
December 1, 2020 – Medical imaging ...
Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.